Supriya Lifescience Q1 Results
- BSE: 543434
- NSE: SUPRIYA
- ISIN: INE07RO01027
- Sector: Biotechnology & Drugs
BSE
900
-18.75 (-2.04%)
-18.75 (-2.04%)Volume16.14 K
Updated: Fri 11 Sep, 2026 | 15:25:17
NSE
904.40-13.05 (-1.42%)
-13.05 (-1.42%)Volume2.09 L
Updated: Fri 11 Sep, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹189.75 Cr.(30.79%)
- Operating Profit₹38.52 Cr.(-14.88%)
- Profit After Tax₹24.04 Cr.(-30.89%)
- Operating Margin20.30%(-34.92%)
Note: Comparison is on YoY basis
Quarterly - Supriya Lifescience Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 151.23 | 187.41 | -19.31% | 102.74 | 51.50% |
| Depreciation/ Amortization | 8.94 | 8.50 | 5.20% | 4.66 | 38.58% |
| Operating Income | 38.52 | 89.12 | -56.78% | 57.89 | -14.88% |
| Net Income | 24.04 | 74.23 | -67.61% | 44.64 | -30.89% |
| Other Operating Expenses Total | 57.41 | 48.77 | 17.73% | 29.40 | 47.54% |
| Net Income Before Taxes | 40.79 | 92.13 | -55.72% | 59.77 | -13.96% |
| Total Revenue | 189.75 | 276.53 | -31.38% | 160.63 | 30.79% |
| Selling/ General/ Admin Expenses Total | 28.49 | 24.82 | 14.80% | 20.08 | 25.57% |
| Diluted Normalized EPS | 2.99 | 9.22 | -67.57% | 5.54 | -30.79% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.